Nk-1 receptor antagonists for the treatment of symptoms of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/395 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/439 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01)

Patent

CA 2235438

Abstract The present invention relates to a pharmaceutical composition for treating or preventing symptoms of irritable bowel syndrome in a mammal, including a human, comprising a compound that is an NK-1 receptor antagonist, in particular a substance P receptor antagonist, together with a pharmaceutically acceptable diluent or carrier.

La présente invention concerne une composition pharmaceutique destinée au traitement ou à la prévention des symptômes du syndrome du côlon irritable chez les mammifères, y compris les humains, comprenant un composé qui est un antagoniste des récepteurs de NK-1, et plus particulièrement un antagoniste des récepteurs de la substance P, ainsi qu'un diluant ou un transporteur acceptable sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nk-1 receptor antagonists for the treatment of symptoms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nk-1 receptor antagonists for the treatment of symptoms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists for the treatment of symptoms of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1512449

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.